TOFRANIL-PM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tofranil-pm, and when can generic versions of Tofranil-pm launch?
Tofranil-pm is a drug marketed by Specgx Llc and is included in one NDA.
The generic ingredient in TOFRANIL-PM is imipramine pamoate. There are thirty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tofranil-pm
A generic version of TOFRANIL-PM was approved as imipramine pamoate by HIKMA on April 16th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOFRANIL-PM?
- What are the global sales for TOFRANIL-PM?
- What is Average Wholesale Price for TOFRANIL-PM?
Summary for TOFRANIL-PM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 14 |
Clinical Trials: | 5 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TOFRANIL-PM at DailyMed |
![TOFRANIL-PM drug patent expirations Drug patent expirations by year for TOFRANIL-PM](/p/graph/s/t/TOFRANIL-PM-patent-expirations.png)
Recent Clinical Trials for TOFRANIL-PM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sheppard Pratt Health System | N/A |
Central Michigan University | N/A |
University of Alabama at Birmingham | N/A |
US Patents and Regulatory Information for TOFRANIL-PM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |